Regulatory Updates
Sep 28, 2026•1 min read
FDA Supplemental Approvals for Quinidine Sulfate Oral Tablet
The FDA records show multiple approved supplemental submissions for the discontinued 200 mg oral tablet of quinidine sulfate, covering manufacturing and labeling.
Regulatory Updates
Sep 22, 2026•1 min read
FDA Approves Multiple Supplemental Applications for Discontinued Chlorothiazide Tablets (ANDA 084217)
The FDA record for ANDA 084217 lists two discontinued oral chlorothiazide tablets (500 mg and 250 mg) and a series of approved supplemental submissions covering manufacturing, labeling and bioequivalence.
Regulatory Updates
Sep 22, 2026•1 min read
FDA Approval History for Discontinued Ophthalmic Product Naphazoline Hydrochloride
The FDA records show original approval in 1974 and multiple supplemental approvals for the ophthalmic solution Naphazoline Hydrochloride, now listed as discontinued.
Regulatory Updates
Aug 30, 2026•1 min read
FDA Approves Multiple Supplemental Submissions for Procaineamide Hydrochloride Capsules (Discontinued)
The FDA has approved several supplemental labeling and manufacturing submissions for the oral capsule product Procaineamide Hydrochloride, which is currently listed as discontinued.